Trials that use: Intention-to-treat analysis
New to this method? Read the tutorial →
15,879 results
- Duloxetine for Chronic Depression: a Double-blind Study: Complete Statistical AnalysisIndependent statistical analysis of Duloxetine for Chronic Depression: a Double-blind Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00360724).
- Duloxetine for Menopausal Depression: Complete Statistical AnalysisIndependent statistical analysis of Duloxetine for Menopausal Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01117857).
- Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome: Complete Statistical AnalysisIndependent statistical analysis of Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00114127).
- Duloxetine for the Treatment of Chronic Pelvic Pain: Complete Statistical AnalysisIndependent statistical analysis of Duloxetine for the Treatment of Chronic Pelvic Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01451606).
- Duloxetine in Patients With Diabetic in Peripheral Neuropathic Pain With or Without Co-morbid Major Depressive Disorder: Complete Statistical AnalysisIndependent statistical analysis of Duloxetine in Patients With Diabetic in Peripheral Neuropathic Pain With or Without Co-morbid Major Depressive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Duloxetine Treatment in Elderly With Dysthymia: Complete Statistical AnalysisIndependent statistical analysis of Duloxetine Treatment in Elderly With Dysthymia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01852383).
- DUO-EIndependent statistical analysis of Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- DUO-OIndependent statistical analysis of Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients: primary endpoint results, effect estimate with confidence…
- Dupilumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus: Complete Statistical AnalysisIndependent statistical analysis of Dupilumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Dupilumab in Japanese Patients With Chronic Rhinosinusitis With Nasal Polyp (SINUS-M52): Complete Statistical AnalysisIndependent statistical analysis of Dupilumab in Japanese Patients With Chronic Rhinosinusitis With Nasal Polyp (SINUS-M52): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- DUR-928 in Subjects With SARS-CoV-2 With Acute Lung, Liver or Kidney Injury: Complete Statistical AnalysisIndependent statistical analysis of DUR-928 in Subjects With SARS-CoV-2 With Acute Lung, Liver or Kidney Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Durability of Hypertonic Saline for Enhancing Mucociliary Clearance in Cystic Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of Durability of Hypertonic Saline for Enhancing Mucociliary Clearance in Cystic Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Durability of Two Skin Barrier Protectants (SBP): Complete Statistical AnalysisIndependent statistical analysis of Durability of Two Skin Barrier Protectants (SBP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05756348).
- DuraGen Plus® Adhesion Barrier for Use in Spinal Surgery: Complete Statistical AnalysisIndependent statistical analysis of DuraGen Plus® Adhesion Barrier for Use in Spinal Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00387829).
- Dural Puncture Epidural Versus Epidural Anesthesia for Cesarean Delivery: Complete Statistical AnalysisIndependent statistical analysis of Dural Puncture Epidural Versus Epidural Anesthesia for Cesarean Delivery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03915574).
- Duration of Analgesia After Popliteal Fossa Nerve Blockade: Effects of Dexamethasone and Buprenorphine: Complete Statistical AnalysisIndependent statistical analysis of Duration of Analgesia After Popliteal Fossa Nerve Blockade: Effects of Dexamethasone and Buprenorphine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Duration of Benefit for OnabotulinumtoxinA in Treatment of Chronic Migraine: Complete Statistical AnalysisIndependent statistical analysis of Duration of Benefit for OnabotulinumtoxinA in Treatment of Chronic Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02037425).
- Duration of Effect of Biotene Spray in Patients With Dry Mouth: Complete Statistical AnalysisIndependent statistical analysis of Duration of Effect of Biotene Spray in Patients With Dry Mouth: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Duration of hSBA Response After a Primary Series of Bivalent rLP2086 Followed by a Booster Dose: Complete Statistical AnalysisIndependent statistical analysis of Duration of hSBA Response After a Primary Series of Bivalent rLP2086 Followed by a Booster Dose: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Duration of Infusion Set Function: Quick-Set Teflon Catheter Versus Sure-T Steel Infusion Set Catheter: Complete Statistical AnalysisIndependent statistical analysis of Duration of Infusion Set Function: Quick-Set Teflon Catheter Versus Sure-T Steel Infusion Set Catheter: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH: Complete Statistical AnalysisIndependent statistical analysis of Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis: Complete Statistical AnalysisIndependent statistical analysis of Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01753830).
- Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage I, II and IIIA Non-small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage I, II and IIIA Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Durvalumab and Stereotactic Radiotherapy for Advanced NSCLC: Complete Statistical AnalysisIndependent statistical analysis of Durvalumab and Stereotactic Radiotherapy for Advanced NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04786093).
- Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC: Complete Statistical AnalysisIndependent statistical analysis of Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Durvalumab and Tremelimumab for Pediatric Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Durvalumab and Tremelimumab for Pediatric Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03837899).
- Durvalumab for MSI-H or POLE Mutated Metastatic Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Durvalumab for MSI-H or POLE Mutated Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03435107).
- Durvalumab, Tremelimumab and Hypofractionated Radiation Therapy in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Durvalumab, Tremelimumab and Hypofractionated Radiation Therapy in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size…
- DUS on the Prescribing Indications for CPA/EE in 5 European Countries: Complete Statistical AnalysisIndependent statistical analysis of DUS on the Prescribing Indications for CPA/EE in 5 European Countries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH): Complete Statistical AnalysisIndependent statistical analysis of Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia: Complete Statistical AnalysisIndependent statistical analysis of Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01231607).
- Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS: Complete Statistical AnalysisIndependent statistical analysis of Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- DVIndependent statistical analysis of Dosing Validation Study of Oral Testosterone Undecanoate (TU, LPCN 1021).: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03242590).
- DW224-III-3Independent statistical analysis of A Study to Evaluate Efficacy and Safety Profile of Zabofloxacin Tablet 400mg and Moxifloxacin Tablet 400mg: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- DWETRIndependent statistical analysis of A Study to Compare the Pharmacokinetic Profiles of Etravil® Tablet 10mg and Etravil® Tablet 25mg: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- DYADIndependent statistical analysis of Efficacy of Switching to DTG/3TC in Virologically-suppressed Adults Currently on B/F/TAF: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- DyeVert™ Plus Contrast Reduction System Multicenter Observational Study: Complete Statistical AnalysisIndependent statistical analysis of DyeVert™ Plus Contrast Reduction System Multicenter Observational Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03715452).
- Dymista Allergen Chamber – Onset of Action Study: Complete Statistical AnalysisIndependent statistical analysis of Dymista Allergen Chamber - Onset of Action Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04652245).
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Measure Response to Etanercept in Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Measure Response to Etanercept in Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Dynamic Locking Screws 5.0 vs. Standard Locking Screws in Fracture of Distal Femur Treated With Locked Plate Fixation: Complete Statistical AnalysisIndependent statistical analysis of Dynamic Locking Screws 5.0 vs. Standard Locking Screws in Fracture of Distal Femur Treated With Locked Plate Fixation: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- DYNAMOIndependent statistical analysis of A Study of Duvelisib in Participants With Refractory Indolent Non-Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Dynasplint Therapy for Trismus in Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Dynasplint Therapy for Trismus in Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00507208).
- DysmenorrheaIndependent statistical analysis of Continuous Administration of Oral Contraceptive, Primary Dysmenorrhea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00517556).
- Dysport® Adult Upper Limb Spasticity Extension Study: Complete Statistical AnalysisIndependent statistical analysis of Dysport® Adult Upper Limb Spasticity Extension Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01313312).
- Dysport® Pediatric Lower Limb Spasticity Follow-on Study: Complete Statistical AnalysisIndependent statistical analysis of Dysport® Pediatric Lower Limb Spasticity Follow-on Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01251380).
- Dysregulation of FSH in Obesity: Functional and Statistical Analysis: Complete Statistical AnalysisIndependent statistical analysis of Dysregulation of FSH in Obesity: Functional and Statistical Analysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02478775).
- DYSTANCE 51Independent statistical analysis of Efficacy and Safety Study of WVE-210201 (Suvodirsen) With Open-label Extension in Ambulatory Patients With Duchenne Muscular Dystrophy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- DYVINIAIndependent statistical analysis of Dysport in Vulvodynia Phase II Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03598777).
- E-3PTSDIndependent statistical analysis of Enhancing Equitable and Effective (E-3) Post Traumatic Stress Disorder (PTSD) Disability Assessment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- E-Cigarette Effects on Markers of Cardiovascular and Pulmonary Disease: Complete Statistical AnalysisIndependent statistical analysis of E-Cigarette Effects on Markers of Cardiovascular and Pulmonary Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03863509).